Not all of the dangerous, controversial drugs are banned in baseball

64 Comments

We get up in arms about testosterone and HGH — substances our bodies naturally produce and which have few serious side effects or long-lasting consequences — because they’re on a banned list. Meanwhile there’s a drug that a lot of athletes take under the direction and supervision of their teams which can kill people and is banned in several countries: the anti-inflammatory Toradol.

Gordon Edes of ESPN Boston has a story about its use in baseball. The hook: an interview with Jonathan Papelbon who took it routinely when he was with the Red Sox but who was told by the Phillies that he can no longer take it as they do not allow it.  Edes looks into the controversial drug, notes its serious side effects, which can include internal bleeding (Clay Buchholz believes it’s what led to him contracting esophagitis which landed him in the ICU) and notes that it’s banned in several countries, for athletes and normal folks alike.

Papelbon’s description of its use in Major League Baseball is pretty familiar-sounding: it’s taken before the game to help guys “get through a 162 game season.” It’s, by definition, a performance enhancing drug. It’s letting guys do things they otherwise couldn’t do. Allowing their bodies to recover faster which allows them to train harder and compete at a more intense level than they otherwise could. Except it’s not on a banned list so no one cares despite the fact that it has the potential to kill you.

There is a tremendous disconnect between the drugs people think are awful in sports and the drugs that truly have the potential to be harmful. This is maybe the best example. Might be nice if we thought about our priorities about these things once in a while.

Steven Wright undergoes procedures on left knee

Greg Fiume/Getty Images
Leave a comment

The Red Sox announced that starter Steven Wright underwent a left knee arthroscopy and debridement on Monday in New York. There is no timetable yet for his recovery, so it is still not known if he will be ready for spring training.

Wright, 34, was bothered by left knee issues throughout the 2018 season. He made four starts and 16 relief appearances totaling 53 2/3 innings, posting a 2.68 ERA with 42 strikeouts and 26 walks. Wright was on the ALDS roster but was removed due to the knee issue and did not appear in the postseason.

Wright is entering his second of three years of arbitration eligibility. He is due a raise on his $1.1 million salary. The Red Sox could non-tender him, but that seems unlikely.